Nichd: r & d: biological testing facility - drug product manufacture of ongoing clinical development: non-severable
Ended Awarded Last action
- Contract number
- 75N94025F00007
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $49,149
Award facts
- Contract value 6% obligated
-
- $49,149.01 Current, with exercised options
- $773,798.26 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $49,149 |
About this award
Sri International, a non-profit research and development organization headquartered in Menlo Park, California, has been awarded a delivery order valued at $773,798.26 under Task Order 27 for drug product manufacture of ongoing clinical development. This contract, issued by the National Institute of Child Health and Human Development (NICHD) under a Cost Plus Fixed Fee pricing structure, is non-severable and carries an ultimate completion date of July 31, 2030. The work will be performed at Sri International's facility in Menlo Park, California. No small business set-aside was applied to this award, reflecting Sri International's status as an established research organization with substantial federal contracting experience.
This delivery order represents part of Sri International's ongoing engagement with the NICHD in providing research and development services for biological testing and drug product manufacturing capabilities. The contract aligns with the organization's demonstrated expertise in biomedical sciences and its established relationships with the National Institutes of Health and its component institutes. Sri International's track record of delivering specialized manufacturing and testing services for clinical development programs positions it to support the NICHD's objectives in advancing child health research and therapeutic development.
Quick answers
Who was awarded contract 75N94025F00007?
75N94025F00007 was awarded to Sri International by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2025.
How much is contract 75N94025F00007 worth?
The government has obligated $49,149 on 75N94025F00007. Its potential value, with all options, is $773,798.
Is contract 75N94025F00007 an order under another contract?
Yes. 75N94025F00007 is a delivery order under 75N94020D00003, an indefinite delivery contract.
Was contract 75N94025F00007 competed?
The extent of competition for 75N94025F00007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award